Literature DB >> 1974409

Gaucher disease associated with a unique KpnI restriction site: identification of the amino-acid substitution.

E Beutler1, T Gelbart.   

Abstract

In an earlier survey of the glucocerebrosidase locus using 20 restriction enzymes and a 1039 bp probe we found that 1 of 9 Gaucher disease patients had a unique pattern with KpnI. a pattern that was not observed in any other Gaucher patient or in 31 controls. We have now localized the mutation in this patient to a T----A transversion in nucleotide 764 of the cDNA occurring on one of the two glucocerebrosidase alleles. The presumed abnormality in the other allele has not been identified. The deduced amino-acid change in the allele with the mutation at nucleotide 764 is a relatively drastic alteration of amino acid 255 from phenylalanine to tyrosine. The genomic DNAs of 31 other Gaucher disease patients (representing 62 Gaucher disease alleles) were examined for this mutation using the polymerase chain reaction. None were found to have this abnormality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974409     DOI: 10.1111/j.1469-1809.1990.tb00371.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  8 in total

1.  Editing of human alpha-galactosidase RNA resulting in a pyrimidine to purine conversion.

Authors:  F J Novo; A Kruszewski; K D MacDermot; G Goldspink; D C Górecki
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

Review 2.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

3.  Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients.

Authors:  M E Grace; R J Desnick; G M Pastores
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.

Authors:  M E Grace; P Ashton-Prolla; G M Pastores; A Soni; R J Desnick
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

5.  Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes.

Authors:  M E Grace; A Berg; G S He; L Goldberg; M Horowitz; G A Grabowski
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

6.  Glucocerebrosidase mutations in Gaucher disease.

Authors:  E Beutler; A Demina; T Gelbart
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

7.  Molecular characterisation of type 1 Gaucher disease families and patients: intrafamilial heterogeneity at the clinical level.

Authors:  O Amaral; A M Fortuna; L Lacerda; R Pinto; M C Sa Miranda
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

8.  Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.

Authors:  E Beutler; T Gelbart; W Kuhl; J Sorge; C West
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.